CD4 mimic compound with anti-HIV activity
US-12508251-B2 · Dec 30, 2025 · US
Japan As Represented By Director General Of Nat Institute Of Infectious Diseases was listed as an assignee on 6 patent publications in 2025.
| Metric | Value |
|---|---|
| Company | Japan As Represented By Director General Of Nat Institute Of Infectious Diseases |
| Year | 2025 |
| Patents | 6 |
Representative publications for Japan As Represented By Director General Of Nat Institute Of Infectious Diseases in 2025.
US-12508251-B2 · Dec 30, 2025 · US
US-12491240-B2 · Dec 9, 2025 · US
US-2025155434-A1 · May 15, 2025 · US
US-2025110123-A1 · Apr 3, 2025 · US
US-2025102519-A1 · Mar 27, 2025 · US
Most common classification codes for Japan As Represented By Director General Of Nat Institute Of Infectious Diseases in 2025.
| CPC | Patents |
|---|---|
| G01N2469/20 | 3 |
| G01N33/56922 | 3 |
| A61K39/12 | 2 |
| A61K39/145 | 2 |
| A61P31/16 | 2 |
Navigate to parent entity pages.